WHO approves fourth single-dose cervical cancer vaccine

Date:

A fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin, has been confirmed for use in a single-dose schedule to prevent cervical cancer, a statement said.

This important milestone will contribute to improving sustainable supply of HPV vaccines—allowing more girls to be reached with the vaccines that prevent the cancer, the WHO statement said on Friday.

WHO Director-General Dr Tedros Adhanom Ghebreyesus said, “Unlike most other cancers, we have the ability to remove cervical cancer, along with its painful inequities.”

More than 95 percent of the 660,000 cervical cancer cases occurring globally every year are caused by HPV. In Every two minutes, a woman dies from this preventable disease globally, and 90 percent of these deaths occur in low- and middle-income countries.

Of the 20 hardest hit countries caused by cervical cancer 19 are in Africa.

spot_img

Share post:

Subscribe

Adspot_imgspot_img

Popular

More like this
Related

US: Two people injured after two planes collide at Miami Airport

Two people were injured after two planes collided on...

South Korean Presidential office weighs life without parole as part of public safety push

South Korea's presidential office said on Sunday it is...

Iran’s IRGC says drones hit US air defence radar station in Bahrain

Iran's Islamic Revolutionary Guard Corps (IRGC) said on Sunday...

Houthis advance toward Yemen’s Aden as gov’t forces suffer fresh setbacks

Yemen's Houthi fighters seized key military positions in the...